Robotic gynaecological surgery using Senhance® robotic platform: Single centre experience with 100 cases - 16/01/21
, Narimantas Evaldas Samalavicius a, b, dBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 4 |
| Iconographies | 2 |
| Vidéos | 0 |
| Autres | 0 |
Abstract |
Objective |
In this article, we present the first 100 gynaecological robotic surgeries in Klaipeda University Hospital, Klaipeda, Lithuania.
Study Design |
A prospective analysis was performed of 100 women age range 22–82, on average 52 years. Patients underwent various robotic gynaecological operations, 61 (61 %) procedures were robotic total hysterectomy with bilateral salpingo-oophorectomy.
Results |
Duration of the surgery varied from 30 min to 185 min, on average 99 ± 33 min. Of all 25 (25 %) patients had operations in the past. Most operations (72 %) were performed for benign diseases and 28 % of the patients were operated for various types of gynaecological malignancies. All cancer surgeries were radical (R0). In-hospital stay was on average 4 ± 2.3 days, range 1–14 days. There were six (6%) conversions: one to laparoscopy and five to open. Three (3%) complications occurred during 30 days after surgery, one demanded surgery (Clavien-Dindo II-IIIb). There was no mortality in this patient population.
Conclusion |
Our early experience with different types of robotic gynaecological surgeries allows us to state that Senhance® robotic system is feasible and safe in gynaecology.
Le texte complet de cet article est disponible en PDF.Keywords : Gynaecology, Minimally invasive surgery, Robotic surgery, Senhance robotic system
Plan
Vol 50 - N° 1
Article 102031- janvier 2021 Retour au numéro
Article précédent
- Prophylactic use of tranexamic acid for decreasing the blood loss in elective cesarean section: A placebo-controlled randomized clinical trial
- Zahra Naeiji, Negar Delshadiyan, Sorayya Saleh, Atefeh Moridi, Nayereh Rahmati, Marzieh Fathi
- The efficacy of different insulin-sensitizing agents on treatment outcomes in patients with polycystic ovary syndrome who underwent in-vitro fertilization: A retrospective, record-based, comparative study
- Aslı Yaylalı, Murat Bakacak, Zeyneb Bakacak
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?